Skip to main content
Displaying 25 - 36 of 42
Display:
12
24
48
Viral Hepatitis
Benefits and barriers to achieving functional cure
Webcasts
View
Viral Hepatitis
The importance of quantitative hepatitis B surface antigen in achieving functional cure: A clinical perspective
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What is the unmet burden of itch from a patient perspective?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
IBAT inhibition: a tool for the future?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What are the unmet needs in PBC according to a patient advocate?
Webcasts
View
Viral Hepatitis
Strategies for achieving functional cure
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Why is holistic care important for patients with PBC?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a UK healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a US healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Closing remarks
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Final audience questions
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Should we focus on managing QoL?
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy